NOTICE

This website is archived for historical purposes and is no longer being maintained or updated.

Skip directly to site content Skip directly to page options Skip directly to A-Z link
Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
For a full list of topics: A-Z Index
Advanced Search
Advanced Search
Severe Acute Respiratory Syndrome (SARS)
    CDC Home
    • Facebook
    • Twitter
    • LinkedIn
    • Syndicate

    Community Containment, Including Quarantine

    Minus
    Related Pages
    • Community Containment Measures, Including Non-Hospital Isolation and Quarantine (Jan 8, 2004)
      Supplement D of
      Public Health Guidance for Community-Level Preparedness and Response to SARS
    • Interventions for Community Containment (Jan 8, 2004)
      Appendix D1, Supplement D of
      Public Health Guidance for Community-Level Preparedness and Response to SARS
    • Preparedness Checklist for Community Containment Measures (Jan 8, 2004)
      Appendix D5, Supplement D of
      Public Health Guidance for Community-Level Preparedness and Response to SARS
    • Frequently Asked Questions about Use of Community Containment Measures (Jan 8, 2004)
      Appendix D2, Supplement D of
      Public Health Guidance for Community-Level Preparedness and Response to SARS
    • Guidelines for Evaluating Homes and Facilities for Isolation and Quarantine (Jan 8, 2004)
      Appendix D3, Supplement D of
      Public Health Guidance for Community-Level Preparedness and Response to SARS
    • Fact Sheet on Isolation and Quarantine (Jan 20, 2004)
    • Fact Sheet on Legal Authorities for Isolation/Quarantine (Jan 20, 2004)
    • Executive Order: Revised List of Quarantinable Communicable Diseases (Apr 4, 2003)
    • Questions and Answers on the Executive Order and Interim Final Rule (Jan 20, 2004)

     Top of Page

    Related Pages
    • Legal Authorities for Isolation and Quarantine
    • Questions about Travel and Quarantine
    Page last reviewed: May 3, 2005
    Content source: National Center for Immunization and Respiratory Diseases, Division of Viral Diseases
    home SARS Home
    • About SARS expand
      • Basics Fact Sheet expand
        • Fact Sheet for SARS Patients and Their Close Contacts
      • Frequently Asked Questions expand
        • Questions and Answers on Executive Order and Interim Final Rule
      • U.S. Government Web sites
      • WHO and Other International Websites
    • Specific Groups and Settings expand
      • Patients
      • Clinicians
      • Legal Professionals
      • Health Departments
      • Laboratory Information
    • Clinical Evaluation and Diagnosis expand
      • Clinical Guidance
      • Preparedness Planning
      • Respiratory Protection
    • Infection Control expand
      • Guidance for Persons Who May Have Been Exposed to SARS
    • Guide for Communities expand
      • Core Document expand
        • Executive Summary
        • I. Introduction
        • II. Overview of the Guidance Document
        • III. Approach to SARS Preparedness and Response
        • IV. Key Measures for SARS Preparedness and Response
        • V. Organization of the Guidance Document
        • References
        • Appendix 1
        • Appendix 2
      • Command and Control expand
        • Summary
        • I. Rationale and Goals
        • II. Lessons Learned
        • III. Operational Authority
        • IV. Incident Command and Management System
        • V. Legal Authority
        • Appendix A1
        • Appendix A2
        • Appendix A3
      • Surveillance expand
        • Summary
        • I. Rationale and Goals
        • II. Lessons Learned
        • III. SARS-CoV Disease
        • IV. Plan for Surveillance of Cases of SARS-CoV Disease
        • V. Reporting of Cases of SARS-CoV Disease
        • VI. Plan for Surveillance of Contacts of SARS Cases
        • VII. Information Management
        • Appendix B1
      • Preparedness and Response in Healthcare Facilities expand
        • Summary
        • I. Rationale and Goals
        • II. Lessons Learned
        • III. Preparedness Planning for Healthcare Facilities
        • IV. Recommended Preparedness and Response Activities in Healthcare Facilities
        • V. Community Healthcare Delivery Issues
        • References
        • Appendix C1
        • Appendix C2
      • Community Containment, Non-Hospital Isolation and Quarantine expand
        • Summary
        • I. Rationale and Goals
        • II. Lessons Learned
        • III. Management of SARS Patients in Isolation
        • IV. Management of Contacts of SARS Cases
        • V. Community-Based Control Measures
        • VI. Enforcement of Community Containment Measures
        • VII. Roles and Responsibilities
        • Appendix D1
        • Appendix D2
        • Appendix D3
        • Appendix D4
        • Appendix D5
      • Managing International Travel-Related Transmission Risk expand
        • Summary
        • I. Rationale and Goals
        • II. Lessons Learned
        • III. Activities Directed to Inbound Travelers
        • IV. Activities Directed to Outbound Travelers
        • V. Activities Related to SARS on Conveyances
        • VI. De-Escalation of Control Measures
        • VII. Roles and Responsibilities
        • VIII. Preparedness Planning
        • Appendix E1
      • Laboratory Guidance expand
        • Summary
        • I. Rationale and Goals
        • II. Lessons Learned
        • III. Diagnostic Assays
        • Appendix F5
        • Appendix F6
      • Communication and Education expand
        • Summary
        • I. Rationale and Goals
        • II. Lessons Learned
        • III. Key Messages
        • IV. Preparing for a Communications Response
        • V. Communications Activities in the Presence of SARS
        • VI. SARS Educational Tools and Resources
        • Appendix G1
        • Appendix G2
        • Appendix G3
        • Appendix G4
      • Infection Control in Healthcare, Home, and Community Settings expand
        • Summary
        • I. Rationale and Goals
        • II. Lessons Learned
        • III. Infection Control in Healthcare Facilities
        • IV. Infection Control for Prehospital Emergency Medical Services (EMS)
        • V. Infection Control for Care of SARS Patients at Home
        • VI. Infection Control for Care of SARS Patients in Community Isolation Facilities
        • VII. Infection Control for Public Health and Outreach Workers
        • VIII. Infection Control for Laboratory and Pathology Procedures
        • IX. Occupational Health Issues
        • Appendix I1
        • Appendix I2
      • Slide Sets
    • Community Containment, Including Quarantine expand
      • Fact Sheet on Isolation and Quarantine
      • Executive Order
      • Executive Order Questions and Answers
    • News and Alerts Archive
    • Laboratory Testing & Specimens expand
      • SARS-Associated Coronavirus (SARS-CoV) Sequencing
      • Specimen Collection and Management
      • Laboratory Testing and Diagnosis
      • Laboratory Biosafety
      • SARS-Associated Coronavirus (SARS-CoV) Images
    • Surveillance and Reporting expand
      • Absence of SARS-CoV Transmission Worldwide
    • Guidance for Travel expand
      • Americans Living Abroad
      • Travel to Areas with SARS
      • Guidance for Airline Personnel
      • Guidance on Air Medical Transport for SARS Patients
    • Legal Authorities for Isolation and Quarantine expand
      • Fact Sheet
    • References and Resources
    Related Links
    • Clinician Registry
    • Travelers' Health
    HAVE QUESTIONS?
    Visit CDC-INFO
    Call 800-232-4636
    Email CDC-INFO
    Open 24/7
    CDC INFORMATION
    • About CDC
    • Jobs
    • Funding
    • Policies
    • File Viewers & Players
    • Other Languages
    • Privacy
    • FOIA
    • No Fear Act
    • OIG
    • Nondiscrimination
    • Accessibility
    • Vulnerability Disclosure Policy | Español
    CONNECT WITH CDC
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    • Snapchat

    • Youtube
    • Syndicate
    • CDC TV
    • RSS
    • Email
    CONTACT CDC
    Visit CDC-INFO
    Call 800-232-4636
    Email CDC-INFO
    Open 24/7
    ABOUT CDC
    • About CDC
    • Jobs
    • Funding
    POLICIES
    • Policies
    • File Viewers & Players
    • Other Languages
    • Privacy
    • FOIA
    • No Fear Act
    • OIG
    • Nondiscrimination
    • Accessibility
    • Vulnerability Disclosure Policy | Español
    • CDC Website Exit Disclaimer external icon
    LANGUAGE ASSISTANCE
    • Español
    • 繁體中文
    • Tiếng Việt
    • 한국어
    • Tagalog
    • Русский
    • العربية
    • Kreyòl Ayisyen
    • Français
    • Polski
    • Português
    • Italiano
    • Deutsch
    • 日本語
    • فارسی
    • English
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    • Snapchat
    • Youtube
    • Syndicate
    • CDC TV
    • RSS
    • Email
    U.S. Department of Health & Human Services
    USA.gov
    CDC Website Exit Disclaimer external icon
    • Facebook
    • Twitter
    • LinkedIn
    SAS stats

    Exit Notification / Disclaimer Policy

    Links with this icon indicate that you are leaving the CDC website.
    • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
    • Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
    • You will be subject to the destination website's privacy policy when you follow the link.
    • CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
    For more information on CDC's web notification policies, see Website Disclaimers.